MEVPAFA Trademark

Trademark Overview

On Thursday, November 7, 2019, a trademark application was filed for MEVPAFA with the United States Patent and Trademark Office. The USPTO has given the MEVPAFA trademark a serial number of 88683720. The federal status of this trademark filing is REGISTERED as of Tuesday, October 24, 2023. This trademark is owned by AstraZeneca AB. The MEVPAFA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation
mevpafa

General Information

Serial Number88683720
Word MarkMEVPAFA
Filing DateThursday, November 7, 2019
Status700 - REGISTERED
Status DateTuesday, October 24, 2023
Registration Number7198382
Registration DateTuesday, October 24, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 28, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 14, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Tuesday, October 24, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 24, 2023REGISTERED-PRINCIPAL REGISTER
Monday, September 18, 20231(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, August 28, 2023NOTICE OF ALLOWANCE CANCELLED
Monday, August 28, 2023TEAS DELETE 1(B) BASIS RECEIVED
Friday, March 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 23, 2023SOU EXTENSION 5 GRANTED
Tuesday, March 14, 2023SOU EXTENSION 5 FILED
Thursday, March 23, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 14, 2023SOU TEAS EXTENSION RECEIVED
Saturday, July 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 28, 2022SOU EXTENSION 4 GRANTED
Thursday, July 28, 2022SOU EXTENSION 4 FILED
Thursday, July 28, 2022SOU TEAS EXTENSION RECEIVED
Saturday, February 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 24, 2022SOU EXTENSION 3 GRANTED
Thursday, February 24, 2022SOU EXTENSION 3 FILED
Thursday, February 24, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, August 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 23, 2021SOU EXTENSION 2 GRANTED
Monday, August 23, 2021SOU EXTENSION 2 FILED
Monday, August 23, 2021SOU TEAS EXTENSION RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 17, 2021SOU EXTENSION 1 GRANTED
Wednesday, February 17, 2021SOU EXTENSION 1 FILED
Wednesday, February 17, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, September 22, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 28, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 22, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 17, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 17, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 16, 2020ASSIGNED TO LIE
Monday, June 8, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 8, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 8, 2020NON-FINAL ACTION E-MAILED
Wednesday, January 8, 2020NON-FINAL ACTION WRITTEN
Tuesday, January 7, 2020ASSIGNED TO EXAMINER
Thursday, November 14, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 11, 2019NEW APPLICATION ENTERED

Related Keywords

mevpafa disorders diseases pharmaceutical anemia substances preparations nervous system inflammation infection